Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate
RATIONALE: Studying samples of blood and tumor tissue from patients with cancer may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. Storing samples to test in the laboratory may help the study of cancer in the future.
PURPOSE: This research study is collecting and storing blood and tumor tissue samples from patients undergoing prostatectomy or transurethral resection of the prostate.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Assessment of Tumor Resistance and Stem Cells in Prostate Cancer|
- Collection and freezing of tumor samples [ Time Frame: 5 years ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
Samples will be collected at time of TURP and will be deidentified and processed by standard procedures.
|Study Start Date:||December 2008|
|Study Completion Date:||December 2008|
|Primary Completion Date:||December 2008 (Final data collection date for primary outcome measure)|
- Collect prostate tissue and other biological specimens for assessment of biological markers that may relate to tumor progression and resistance and for future isolation of stem cells and biologic markers.
Biological samples, including serum and mononuclear cells and tumor tissue, are collected before and during surgery. Specimens are frozen and stored indefinitely.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00991315
|United States, New Jersey|
|Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School|
|New Brunswick, New Jersey, United States, 08903|
|Principal Investigator:||Isaac Kim, MD, PhD||Rutgers Cancer Institute of New Jersey|